1. Home
  2. FSI vs ALXO Comparison

FSI vs ALXO Comparison

Compare FSI & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$7.01

Market Cap

86.6M

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.33

Market Cap

79.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSI
ALXO
Founded
1991
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.6M
79.7M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
FSI
ALXO
Price
$7.01
$1.33
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.30
AVG Volume (30 Days)
28.5K
177.3K
Earning Date
11-14-2025
11-07-2025
Dividend Yield
1.41%
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$38,563,427.00
N/A
Revenue This Year
$7.49
N/A
Revenue Next Year
$53.12
N/A
P/E Ratio
$50.80
N/A
Revenue Growth
0.18
N/A
52 Week Low
$3.46
$0.40
52 Week High
$11.48
$2.27

Technical Indicators

Market Signals
Indicator
FSI
ALXO
Relative Strength Index (RSI) 46.21 42.54
Support Level $6.92 $1.37
Resistance Level $7.26 $1.53
Average True Range (ATR) 0.30 0.11
MACD 0.10 -0.01
Stochastic Oscillator 50.51 12.12

Price Performance

Historical Comparison
FSI
ALXO

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: